Immunitas Therapeutics
Developing targeted therapeutics for patients with challenging, complex cancers by unlocking human immunology using novel single cell analyses. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD316—475m (Dealroom.co estimates Aug 2021.)
Cambridge Massachusetts (HQ)
Authorizing premium user...